Literature DB >> 11181690

Gemcitabine and cisplatin for advanced, metastatic bladder cancer.

M H Cohen, M Rothmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181690     DOI: 10.1200/JCO.2001.19.4.1229

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

1.  Weekly regimen of epirubicin and paclitaxel as second-line chemotherapy in patients with metastatic transitional cell carcinoma of urothelial tract: results of a phase II study.

Authors:  Antonio Rozzi; Margherita Salerno; Francesca Bordin; Ferdinando De Marco; Stefano Di Nicola; Gaetano Lanzetta
Journal:  Med Oncol       Date:  2010-11-30       Impact factor: 3.064

2.  Combined administration of fucoidan ameliorates tumor and chemotherapy-induced skeletal muscle atrophy in bladder cancer-bearing mice.

Authors:  Meng-Chuan Chen; Wen-Lin Hsu; Pa-An Hwang; Yen-Lin Chen; Tz-Chong Chou
Journal:  Oncotarget       Date:  2016-08-09

3.  Anti-cachectic effect of Antrodia cinnamomea extract in lung tumor-bearing mice under chemotherapy.

Authors:  Meng-Chuan Chen; Wen-Lin Hsu; Tz-Chong Chou
Journal:  Oncotarget       Date:  2018-04-13

4.  2-methoxyestradiol induces mitotic arrest, apoptosis, and synergistic cytotoxicity with arsenic trioxide in human urothelial carcinoma cells.

Authors:  Kuan-Lin Kuo; Wei-Chou Lin; I-Lin Ho; Hong-Chiang Chang; Ping-Yi Lee; Yuan-Ting Chung; Ju-Ton Hsieh; Yeong-Shiau Pu; Chung-Sheng Shi; Kuo-How Huang
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

5.  Celecoxib-induced cytotoxic effect is potentiated by inhibition of autophagy in human urothelial carcinoma cells.

Authors:  Kuo-How Huang; Kuan-Lin Kuo; I-Lin Ho; Hong-Chiang Chang; Yuan-Ting Chuang; Wei-Chou Lin; Ping-Yi Lee; Shih-Chen Chang; Chih-Kang Chiang; Yeong-Shiau Pu; Chien-Tso Chou; Chen-Hsun Hsu; Shing-Hwa Liu
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

6.  Supplementation of Magnolol Attenuates Skeletal Muscle Atrophy in Bladder Cancer-Bearing Mice Undergoing Chemotherapy via Suppression of FoxO3 Activation and Induction of IGF-1.

Authors:  Meng-Chuan Chen; Yen-Lin Chen; Chi-Feng Lee; Chih-Huang Hung; Tz-Chong Chou
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

7.  The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-Apoptotic Bcl-2 Protein: In Vitro and In Vivo Study.

Authors:  Kuan-Lin Kuo; Shing-Hwa Liu; Wei-Chou Lin; Po-Ming Chow; Yu-Wei Chang; Shao-Ping Yang; Chung-Sheng Shi; Chen-Hsun Hsu; Shih-Ming Liao; Hong-Chiang Chang; Kuo-How Huang
Journal:  Cells       Date:  2019-10-17       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.